0001209191-19-045228.txt : 20190808 0001209191-19-045228.hdr.sgml : 20190808 20190808193936 ACCESSION NUMBER: 0001209191-19-045228 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190806 FILED AS OF DATE: 20190808 DATE AS OF CHANGE: 20190808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GORMAN KEVIN CHARLES CENTRAL INDEX KEY: 0001201096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 191011016 MAIL ADDRESS: STREET 1: 12790 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-06 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001201096 GORMAN KEVIN CHARLES 12780 EL CAMINO REAL SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer Common Stock 2019-08-06 4 M 0 50911 8.66 A 468508 D Common Stock 2019-08-06 4 S 0 50911 95.1539 D 417597 D Common Stock 2019-08-07 4 M 0 2759 8.66 A 420356 D Common Stock 2019-08-07 4 S 0 2759 95.1216 D 417597 D Common Stock 2019-08-08 4 M 0 26330 8.66 A 443927 D Common Stock 2019-08-08 4 S 0 26330 95.6382 D 417597 D Non-Qualified Stock Option 8.66 2019-08-06 4 M 0 50911 8.66 D 2022-01-12 Common Stock 50911 172538 D Non-Qualified Stock Option 8.66 2019-08-07 4 M 0 2759 8.66 D 2022-01-12 Common Stock 2759 169779 D Non-Qualified Stock Option 8.66 2019-08-08 4 M 0 26330 8.66 D 2022-01-12 Common Stock 26330 143449 D The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.54. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.28. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $95.00 to $96.52. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Option granted January 12, 2012 and vested monthly over four years. /s/ Darin Lippoldt, Attorney-in-Fact 2019-08-08